相关实验视频
Updated: May 30, 2025

05:00
Using a Chemical Biopsy for Graft Quality Assessment
Published on: June 17, 2020
5.1K
用于治疗慢性病的基于脂多米克的天然产品
Rui Zhang1, Jingjing Wang1, Chenguang Wu1
1Renal Division, Department of Medicine, Heilongjiang Academy of Chinese Medicine Sciences, Harbin, China.
Heliyon
|January 27, 2025
概括
慢性病 (CKD) 显示了脂质样本的变化. 脂管学确定了用于CKD治疗的新生物标志物和天然产品,为管理这种普遍存在的全球健康问题提供了新的视角.
科学领域:
- 生物化学 生物化学
- 腎臟病學 (nephrology) 是一種醫學.
- 代谢学 代谢学 代谢学
背景情况:
- 慢性病 (CKD) 是一个普遍存在的全球健康问题,由糖尿病,高血压和肥胖的上升率加剧.
- 目前用于功能的生物标志物缺乏早期CKD检测和监测的灵敏度和特异性.
- 失脂症是CKD的一个特征,突出显示了脂质在疾病进展中的作用.
研究的目的:
- 探索脂质和脂质组在慢性病中的作用.
- 确定新的基于脂质的生物标志物,用于早期CKD诊断和监测.
- 为了研究潜在的CKD治疗应用,从脂管学中提取的天然产品.
主要方法:
- 利用基于先进的质谱 (MS) 的脂质组学平台,对生物样本进行全面的脂质分析.
- 在CKD的背景下分析与代谢障碍相关的脂质组变化.
- 通过脂管学方法识别和表征新生物标志物.
主要成果:
- 脂管组学揭示了与CKD相关的脂管组的显著变化.
- 脏疾病的新生物标志物已被使用脂管学识别出来.
- 通过脂管学发现了对CKD具有治疗潜力的天然产品.
结论:
- 脂管学为了解CKD病原体和识别新的治疗点提供了一种强大的方法.
- 新的脂质生物标志物可以改善早期诊断和对CKD进展的监测.
- 通过脂管学识别的天然产品从脂管学角度来看,有望改善CKD的结果.
更多相关视频
相关概念视频
Lipid-Lowering Drugs: Statins and Miscellaneous Agents
524
Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
524
Hormonal Regulation
32.9K
The renin-aldosterone system is an endocrine system which guides the renal absorption of water and electrolytes, thus managing blood pressure and osmoregulation. Activation of the system begins in the kidneys with a small cluster of cells adjacent to the afferent and efferent blood vessels of the renal corpuscle. As the nephrons are filtering blood, juxtaglomerular cells monitor blood pressure. If they detect a decrease in pressure, they release the hormone renin into the bloodstream.
32.9K

